Onkologie. 2022:16(6):312-316 | DOI: 10.36290/xon.2022.066

Testicular tumors and radiotherapy - minireview

Jiří Petera, Denisa Pohanková, Jan Jansa
Klinika onkologie a radioterapie, FN a LF Hradec Králové

Radiotherapy was till 1960s-1970s of the last century principal part of treatment of both seminomas and nonseminomas. Recognition of relative radiorezistence of nonseminoma limited radiotherapy indication to seminomas only. Further development led to the revisions of indication of adjuvant treatment, to reduction of radiotherapy volumes and doses and to use of chemotherapy as alternative to irradiation. Contemporary radiotherapy has a role in the treatment in stage I-II seminoma in patients not suitable for surveillance or chemotherapy. Three-dimensional conformal radiotherapy is a preferred technique.

Keywords: testicular tumors, radiotherapy.

Accepted: November 22, 2022; Published: November 22, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Petera J, Pohanková D, Jansa J. Testicular tumors and radiotherapy - minireview. Onkologie. 2022;16(6):312-316. doi: 10.36290/xon.2022.066.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Epidemiologie zhoubných nádorů v ČR [online]. Available from: http://www.svod.cz.
    2. Boctor Z, Kurohara S, Badib A, et al. Current results from therapy of testicular tumors. Cancer. 1969;24:870-875. Go to original source...
    3. Patton J, Hewitt C. Diagnosis and treatment of tumors of the testis. JAMA. 1959;2194-2198. Go to original source...
    4. Hanna N, Einhorn L. Testicular cancer: A reflection on 50 years of discovery. Journal of Clinical Oncology. 2014;32:3085-3092. Go to original source... Go to PubMed...
    5. Zamečník J. Radioterapie. Praha: Avicenum; 1982.
    6. Fossa SD, Horwich A, Russel JM, et al. Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Journal of Clinical Oncology. 1999;17:1146-1154. Go to original source... Go to PubMed...
    7. Jones WG, Fossa SD, Mead GM, et al. Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). Journal of Clinical Oncology 2005;23:1200-1208. Go to original source... Go to PubMed...
    8. Oliver RT, Mead GM, Rustin GJS, et al. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature resuts on relapse and contralateral testis cancer rates in MRC TE19/EORTC30982 study. J Clin Oncol. 2011;29:957-962. Go to original source... Go to PubMed...
    9. Tandstat T, Stahl O, Dahl O, et al. Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA). Ann Oncol. 2016;27:1299-1304. Go to original source... Go to PubMed...
    10. Aydin AM, Zemp L, Cheriyan SK, et al. Contemporary management of early stage testicular seminoma. Translational andrology and urology. 2020;9:36-44. Go to original source... Go to PubMed...
    11. Petrelli F, Coinu A, Cabiddu M, et al. Surveillance or adjuvant treatment with chemotherapy or radiotherapy in stage I seminoma: A systematic review and meta-analysisi of 13 studies. Clinical genitourinary cancer. 2015;13:428-434. Go to original source... Go to PubMed...
    12. Glaser SM, Vargo JA, Balasubramani GK, et al. Surveillance and radiation therapy for stage I seminoma - have we learned from the evidence? Int J Radiat Oncol Biol Phys. 2016;94:75-84. Go to original source... Go to PubMed...
    13. Bilici A, Ozturk T, Turkmen E, et al. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolie Society of Medical Oncology. World J Urol. 2015;33:1613-1622. Go to original source... Go to PubMed...
    14. Laguna MP, Albers P, Algaba F, et al. EAU guidelines on testicular cancer 2022. Available from: www.uroweb.org/guidelines/testicular - cancer/.
    15. Honecker F, Aparicio J, Berney D, et al. ESMO consensus konference on testicular germ cell cancer: diagnosis, treatment and follow-up. Ann Oncol. 2018;29:1658-1686. Go to original source... Go to PubMed...
    16. Giannatempo P, Greco T, Mariani L, et al. Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes. Ann Oncol. 2015;26:657-668. Go to original source... Go to PubMed...
    17. Chung P, Warde P. Contemporary management of stage I and II seminoma. Curr Urol Rep. 2013;14:525-533. Go to original source... Go to PubMed...
    18. Available from: www.nccn.org/professionals/physicians-gls/pdf/testicular.pdf.
    19. Martin JM, Joon DL, Ng N, et al. Towards individualised radioterapy for Stage I seminoma. Radiother Oncol. 2005;76:251-256. Go to original source... Go to PubMed...
    20. Wieder RB, Buyyounouski MK, Efstathiou JA, et al. Radiotherapy treatment planning for testicular seminoma. Int J Radiat Oncolo Biol Phys. 2012;83:445-452. Go to original source... Go to PubMed...
    21. Doležalová H, Sovadinová S. Zhoubné nádory varlat. In: Šlampa P. Radiační onkologie. Praha: Maxdorf Jessenius; 2021:434-442.
    22. Pasalic D, Prajapati S, Ludmir EB, et al. Outcomes and toxicities of proton and photon radiation therapy for testicular seminoma. International Journal of Particle Therapy. 2020;7:11-20. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.